Anavex Life Sciences Newsroom

Here Are the Major Earnings Before the Open Tomorrow

Seeking Alpha07:00

Anavex Life Sciences, Limoneira Set to Report Earnings Monday

InvestingDec 21 03:02

Anavex Life Sciences Q4 2024 Earnings Preview

Seeking AlphaDec 20 20:41

Earnings Preview: AVXL to Report Financial Results Pre-market on December 23

$Anavex Life Sciences(AVXL.US)$ is scheduled to release its financial results pre-market on December 23 ET. Earnings PreviewAnalysts estimate $Anavex Life Sciences(AVXL.US)$ to post revenue of USD0

Futu NewsDec 18 09:00

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer's Disease Data at J.P. Morgan 2025 Healthcare Conference

GlobeNewswireDec 9 20:30

Earnings Week Ahead: ORCL, GME, ADBE, COST, AVGO, M and More

Seeking AlphaDec 8 21:01

Anavex Life Sciences Down Over 13%, On Track for Largest Percent Decrease Since January -- Data Talk

Dow JonesDec 6 04:12

Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024

GlobeNewswireDec 2 20:30

Buy Recommendation for Anavex Life Sciences: Promising Alzheimer's Treatment and Expanding Clinical Pipeline

TipRanksNov 27 19:25

Anavex Submits Marketing Authorization Application to EU Regulator for Blarcamesine to Treat Alzheimer's; Shares Jump Pre-Bell

MT NewswiresNov 26 22:29

Express News | Anavex Life Sciences Announces Submission of Blarcamesine Maa for Treatment of Alzheimer’s Disease to EMA

BreakingsNov 26 20:30

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow JonesNov 25 22:15 · Ratings

Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital

Dow JonesNov 25 22:15 · Ratings

Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer's Disease Journal

GlobeNewswireNov 25 20:30

Express News | Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase Iib/III Data in a Reference Alzheimer’s Disease Journal

BreakingsNov 25 20:30

Calendar of U.S. Earnings Expected in the Week Ahead

Dow JonesNov 22 19:00

Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More

Seeking AlphaNov 18 13:09

Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?

Simply Wall StNov 6 21:08

HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $40 Price Target

BenzingaNov 4 19:29 · Ratings

Anavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market Expansion

TipRanksNov 4 19:15 · Ratings